▮▶DailyPrompt
Live
·NYT-led group asks judge to sanction OpenAI over hidden evidence·Anthropic's $1.5B author settlement is a fraction of its $965B valuation·US closes loophole letting Chinese firms buy Nvidia chips overseas·Nvidia's China AI chip market share collapses to near zero·Huawei, Cambricon and SMIC fill the gap Nvidia left in China·Apple unveils Siri AI with personal context awareness·NYT-led group asks judge to sanction OpenAI over hidden evidence·Anthropic's $1.5B author settlement is a fraction of its $965B valuation·US closes loophole letting Chinese firms buy Nvidia chips overseas·Nvidia's China AI chip market share collapses to near zero·Huawei, Cambricon and SMIC fill the gap Nvidia left in China·Apple unveils Siri AI with personal context awareness

Claude Science traces back to a biotech acquisition and a Nobel hire

Anthropic's new research workbench builds on its Coefficient Bio acquisition and the hire of AlphaFold lead John Jumper.

MVMara Vidović
Published 10 Jul 2026, 05:32Updated 28 Jul 2026, 04:411 min read
Claude Science traces back to a biotech acquisition and a Nobel hire

The launch of Claude Science is underpinned by two moves reported this week: Anthropic's acquisition of Coefficient Bio, and the hiring of John Jumper, who led the AlphaFold team at Google DeepMind and shared the 2024 Nobel Prize in Chemistry.

Bringing in a Nobel laureate to help shape a scientific AI product is a strong signal of how seriously Anthropic is chasing credibility with research institutions, not just developers.

Source: Anthropic

#Anthropic#Claude#AI Tools
ShareXLinkedInFacebookEmail

▮Related stories

All →